- Discovery and validation of cfDNA methylation, AFP and ctDNA mutation for the early detection of hepatocellular carcinoma: A multicenter prospective study (ASCEND-Hep)Pan, M.; Wang, C.; Xie, W.; Zhao, K.; Fang, S.; Zhou, Q.; He, J.; Deng, M.; Yang, Y.; Wang, W.; Zhang, Q.; Bao, S.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patientsChen, Lei; Abou-Alfa, Ghassan K.; Zheng, Bo; Liu, Jing-Feng; Bai, Jian; Du, Lu-Tao; Qian, Yun-Song; Fan, Rong; Liu, Xiao-Long; Wu, Lin*; Hou, Jin-Lin*; Wang, Hong-Yang*Cell Research, 2021, 31(5): 589-592.被引 47
- Effective identification of primary liver cancer from cirrhosis or chronic hepatitis virus infection using eight methylated plasma DNA markers: Marker discovery, phase I pilot, and phase II clinical validationYang, T.; Wang, N.; Zhu, X.; Wang, M.; Yao, L.; Fan, Z.; Sun, X.; Pan, M.; Zhang, L.; You, Q.; Xu, J.; Xu, Y.; Lu, H.; Li, B.; Wang, G.; Cai, S.; Shen, F.; Lv, G.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
会议论文
COMBINED METHYLATED DNA AND PROTEIN MARKERS: AN ACCURATE BLOOD-BASED TEST FOR EARLY-STAGE DETECTION OF HEPATOCELLULAR CARCINOMA
5阅读
